Effects of Resistance and Dual-Task Training on Physical, Oculomotor, and Executive Functions in Older Adults With MCI
Study Protocol: Effects of Combined Resistance Training and Dual-Task Interventions on Physical, Oculomotor, and Executive Functions in Older Adults With Mild Cognitive Impairment. A Randomized Controlled Trial
1 other identifier
interventional
66
2 countries
2
Brief Summary
The goal of this clinical trial is to determine the effect of a combined therapeutic intervention program with anaerobic exercises (resistance exercises) and dual tasks on the physical, oculomotor, and executive functions of older adults with mild cognitive impairment. The main questions it aims to answer are:
- How effective will a therapeutic intervention program combining resistance exercises with dual tasks be in improving the physical, oculomotor, and executive functions of older adults with mild cognitive impairment living in the community? Researchers will compare the effectiveness of a resistance exercise training program combined with dual tasks versus a resistance-only exercise training program to see if it improves the physical, oculomotor, and executive functions of older adults with mild cognitive impairment Participants Will:
- Receive resistance exercises, resistance exercises combined with dual tasks. or the standard health care. The intervention programs will consist of 3 weekly sessions over 8 weeks.
- Before the start and after the completion of the programs, they will be evaluated using a battery of tests. This includes sociodemographic and general health background, physical fitness tests, as well as assessments of executive functions and oculomotor Saccadic movements and anti-saccadic error.
- be required to sign a consent form.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2026
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 8, 2025
CompletedFirst Posted
Study publicly available on registry
December 11, 2025
CompletedStudy Start
First participant enrolled
January 17, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 17, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 17, 2026
December 11, 2025
November 1, 2025
10 months
May 8, 2025
November 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Physical-functional condition - Risk of falls
The physical-functional condition, specifically the risk of falls of participants will be assessed using the Timed Up and Go Test (TUG). Description: Time in seconds required to stand up from a chair, walk three meters, turn, return, and sit down. Unit of Measure: Seconds (s)
Baseline, and immediately post-intervention (week 11),
Executive function - Inhibitory control
Participants' inhibitory control will be assessed using the Stroop Colour Test. Performance will be evaluated through response time. Unit of Measure: Milliseconds (ms)
Baseline, and immediately post-intervention (week 11-12)
Oculomotor Function- Saccadic and anti-saccadic oculomotor movement
Saccadic and anti-saccadic eye movements will be assessed using a non-invasive electrooculography (EOG) system (ADInstruments PTK15 EOG model and AD Instruments Brazil PowerLab T26-3079). Two surface electrodes will be placed at the outer canthi of the right and left eyes, with a ground electrode positioned on the forehead. Synchronization between target illumination and EOG signals will be controlled using LabChart software (version 7, Research Ltd.). Performance will be evaluated based on movement latency during visual tasks: left-to-right for saccadic movements and right-to-left for anti-saccadic movements. Unit of Measure: Milliseconds (ms).
Baseline, and immediately post-intervention (week 11)
Physical - functional condition - Physical function
The Physical-functional condition, specifically Participants' physical function will be assessed with the Short Physical Performance Battery (SPPB). Description: Composite score evaluating balance, gait speed, and lower limb strength. Unit of Measure: Points on a scale (0-12).
Baseline, and immediately post-intervention (week 11)
Physical - functional condition - Grip Strength
The Physical-functional condition, specifically the grip strenght of particiants will be assesment with the JAMAR dynamometer. Description: Maximum grip strength measured with a hydraulic dynamometer. Unit of Measure: Kilograms (kg)
Baseline, and immediately post-intervention (week 11)
Executive Function - Working Memory
Working memory will be assessed using the Corsi Block-Tapping Test (CBTT), administered in both forward and backward conditions. Performance will be evaluated based on response time for each condition. Unit of Measure: Milliseconds (ms)
Baseline, and immediately post-intervention (week 11-12)
Executive Function - Cognitive Flexibility
Cognitive flexibility will be assessed using the Trail Making Test (TMT). Performance will be evaluated through completion time for Part A (numbers only) and Part B (numbers and letters alternating). Unit of Measure: Miliseconds (ms).
Baseline, and immediately post-intervention (week 11-12)
Secondary Outcomes (5)
Sociodemographic variable - Age
Baseline
Sociodemographic variable - Sex
Baseline
Sociodemographic variables-Educational Level
Baseline
Health indicators- Comorbidities
Baseline
Anthropometric variable- Body Mass Index (BMI)
Baseline
Study Arms (3)
Intervention Group EGR (Experimental group resistance exercises)
EXPERIMENTALEGR will receive only anaerobic therapeutic exercises (resistance exercises) for 8 weeks, with 3 sessions per week. The exercises will focus on the elbow flexor/extensor groups and the knee flexor/extensor groups, using a bilateral leg press, unilateral knee extensions, and bilateral elbow flexion-extension exercises, performed in 3 sets of 8 repetitions for each trained muscle group.
The EGRD group (Experimental group: resistance exercise plus dual tasks)
EXPERIMENTALThe EGRD group (experimental group: resistance exercise plus dual tasks) will receive 8 weeks of anaerobic therapeutic exercises (resistance exercises) combined with dual tasks during sessions. They will perform the same exercise protocol as the EGR group and concurrently add memory and arithmetic tasks during the exercises.
The CG Group (control group)
NO INTERVENTIONThe control group (CG) will receive usual health care during the intervention period; however, they will receive the best evaluated therapeutic intervention at the end of the study.
Interventions
The intervention period will last 8 weeks, with 3 sessions per week. Each resistance training session will last one hour and will consist of three parts: the first part will include joint mobility and basic preparatory movements; the second part will involve the resistance training itself (with added weight); and finally, the third part will feature breathing exercises and stretches as a cool-down. Weighted exercises will focus on the elbow flexor/extensor groups and the knee flexor/extensor groups through bilateral leg presses, unilateral knee extensions, and bilateral elbow flexion-extension exercises, performed in 3 sets of 8 repetitions for each muscle group trained. The training intensity for the first two weeks will be set at 60% of 1RM and will then be increased to the target intensity (80% of 1RM) by at least week 7 of the training. To ensure that the training program is progressive, a 1RM strength evaluation will be performed every two weeks, to adjust the training load.
The anaerobic (resistance) exercise training group combined with dual tasks will follow the same protocol as the previously described anaerobic therapeutic exercise training and will additionally incorporate memory and arithmetic tasks concurrently during the exercises. The intervention period will also last 8 weeks, with 3 sessions per week, and each training session will last one hour (Pantoja-Cardoso et al. 2023).
Eligibility Criteria
You may qualify if:
- Men and women aged 60 years or older
- Score between 10 and 25 points on the Montreal Cognitive Assessment (MoCA) scale
- Provide informed consent
You may not qualify if:
- Visual or auditory disability that impedes communication
- Previous diagnosis of dementia
- Wheelchair use
- Epilepsy
- Progressive or terminal illness
- Depression
- History of alcoholism
- Musculoskeletal or cardiovascular contraindications for strength exercises
- Color blindness
- Dyslexia
- Severe mental or cognitive problems supported by medical reports
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universidad Santo Tomas, Chilelead
- University of Valenciacollaborator
Study Sites (2)
Arica- Chile y Valencia -España
Arica, Arica y Parinacota Region, 1000000, Chile
Valencia-Spain
Valencia, Valencia, 46001, Spain
Related Publications (4)
Voos MC, Custodio EB, Malaquias J Jr. Relationship of executive function and educational status with functional balance in older adults. J Geriatr Phys Ther. 2011 Jan-Mar;34(1):11-8. doi: 10.1097/JPT.0b013e3181ff2452.
PMID: 21937887BACKGROUNDVandierendonck A. Working memory benchmarks-A missed opportunity: Comment on Oberauer et al. (2018). Psychol Bull. 2018 Sep;144(9):963-971. doi: 10.1037/bul0000159.
PMID: 30148381BACKGROUNDHeath M, Weiler J, Gregory MA, Gill DP, Petrella RJ. A Six-Month Cognitive-Motor and Aerobic Exercise Program Improves Executive Function in Persons with an Objective Cognitive Impairment: A Pilot Investigation Using the Antisaccade Task. J Alzheimers Dis. 2016 Oct 4;54(3):923-931. doi: 10.3233/JAD-160288.
PMID: 27567829BACKGROUNDGlisky EL, Alexander GE, Hou M, Kawa K, Woolverton CB, Zigman EK, Nguyen LA, Haws K, Figueredo AJ, Ryan L. Differences between young and older adults in unity and diversity of executive functions. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2021 Nov;28(6):829-854. doi: 10.1080/13825585.2020.1830936. Epub 2020 Oct 8.
PMID: 33028159BACKGROUND
Related Links
Study Officials
- STUDY DIRECTOR
Jorquera-Caceres I Ivonne, MSc
Universidad Santo Tomas, Chile
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Due to the study design, proper blinding is not feasible, as it is a non-pharmacological within-subject design. The intervention is visible to both the participants and the investigators administering it. To mitigate this issue, in accordance with the CONSORT extension for non-pharmacological trials (Boutron et al., 2017), the study's hypothesis is concealed from the participants, and the outcomes assessor at the beginning and the end of the intervention will be blinded to the participants' intervention group.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physical therapist, MSc
Study Record Dates
First Submitted
May 8, 2025
First Posted
December 11, 2025
Study Start
January 17, 2026
Primary Completion (Estimated)
November 17, 2026
Study Completion (Estimated)
December 17, 2026
Last Updated
December 11, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
Personal information and data for all experiments are handled by the personal information manager director of Valencia University. Access to information requires a key that is securely kept and has limited access. These internal checks and balances ensure the security of all data and personal information. After the experimental period ends, the data will be consolidated. Any information linking data backto the participant will be discarded to ensure that the data are truly anonymous.